Prior view was $410M-$450M. Guidance reduction is due to the company’s decision to remove any non-migrant municipal population health revenue from its 2025 guidance. Revenue expectations from the company’s Medical Transportation and Payer & Provider businesses and remaining migrant services healthcare work are unchanged.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO: